Integrated Core Strategies (Asia) buys Biocon shares worth ₹185 cr
It purchased 80,61,599 shares at an average price of ₹229.26 each share
Stay updated with breaking news from Biocon Biologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It purchased 80,61,599 shares at an average price of ₹229.26 each share
Sanofi India, KSB, and Mideast Integrated Steels will be among the stocks in focus as they will declare their December quarter earnings today.
With the current investment in Biocon, the Kotak Special Situation Fund has deployed 100% of its corpus of $1 billion
Kotak Special Situations Fund (KSSF), managed by Kotak Investment Advisors Limited (KIAL), today announced an investment of Rs 1,070 crore in Biocon Limited (BL). Biocon will use the proceeds to finance Biocon Biologics' acquisition of the biosimilars business of its partner Viatris to create a global vertically integrated biosimilars player. -- aaa
Get latest articles and stories on Latest News at LatestLY. A Kotak Mahindra Bank arm on Wednesday announced a Rs 1,070 crore investment in Biocon to help a subsidiary of the Bengaluru-based company in an acquisition. Latest News | Kotak Bank Arm Invests Rs 1,070 Cr in Biocon for Vaitris Acquisition.